{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:05:43Z","timestamp":1787162743545,"version":"build-2736575974"},"reference-count":141,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Bone infection results in a complex inflammatory response and bone destruction. A broad spectrum of bacterial species has been involved for jaw osteomyelitis, hematogenous osteomyelitis, vertebral osteomyelitis or diabetes mellitus, such as\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (\n                    <jats:italic>S. aureus<\/jats:italic>\n                    ), coagulase-negative Staphylococcus species, and aerobic gram-negative bacilli.\n                    <jats:italic>S. aureus<\/jats:italic>\n                    is the major pathogenic bacterium for osteomyelitis, which results in a complex inflammatory response and bone destruction. Although various antibiotics have been applied for bone infection, the emergence of drug resistance and biofilm formation significantly decrease the effectiveness of those agents. In combination with gram-positive aerobes, gram-negative aerobes and anaerobes functionally equivalent pathogroups interact synergistically, developing as pathogenic biofilms and causing recurrent infections. The adhesion of biofilms to bone promotes bone destruction and protects bacteria from antimicrobial agent stress and host immune system infiltration. Moreover, bone is characterized by low permeability and reduced blood flow, further hindering the therapeutic effect for bone infections. To minimize systemic toxicity and enhance antibacterial effectiveness, therapeutic strategies targeting on biofilm and bone infection can serve as a promising modality. Herein, we focus on biofilm and bone infection eradication with targeting therapeutic strategies. We summarize recent targeting moieties on biofilm and bone infection with peptide-, nucleic acid-, bacteriophage-, CaP- and turnover homeostasis-based strategies. The antibacterial and antibiofilm mechanisms of those therapeutic strategies include increasing antibacterial agents\u2019 accumulation by bone specific affinity, specific recognition of phage-bacteria, inhibition biofilm formation in transcription level. As chronic inflammation induced by infection can trigger osteoclast activation and inhibit osteoblast functioning, we additionally expand the potential applications of turnover homeostasis-based therapeutic strategies on biofilm or infection related immunity homeostasis for host-bacteria. Based on this review, we expect to provide useful insights of targeting therapeutic efficacy for biofilm and bone infection eradication.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2022.936285","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T10:15:24Z","timestamp":1655201724000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Mini Review Therapeutic Strategies Targeting for Biofilm and Bone Infections"],"prefix":"10.3389","volume":"13","author":[{"given":"Shizhou","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.2147\/IJN.S298936","article-title":"Nanomaterials-upconverted hydroxyapatite for bone tissue engineering and a platform for drug delivery.","volume":"16","author":"Abdul Halim","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/jor.23755","article-title":"Current review-the rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections.","volume":"36","author":"Akanda","year":"2018","journal-title":"J. Orthop. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/infdis\/jiv212","article-title":"CTLA4 immunoglobulin but not anti-tumor necrosis factor therapy promotes Staphylococcal septic arthritis in mice.","volume":"212","author":"Ali","year":"","journal-title":"J. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/art.38902","article-title":"Antibiotic-killed Staphylococcus aureus induces destructive arthritis in mice.","volume":"67","author":"Ali","year":"","journal-title":"Arthritis Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects.","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1093\/cid\/civ633","article-title":"2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults.","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106060","article-title":"Bioactive coatings with anti-osteoclast therapeutic agents for bone implants: enhanced compliance and prolonged implant life.","volume":"176","author":"Bjelic","year":"2022","journal-title":"Pharmacol. Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1095\/biolreprod57.4.813","article-title":"Identification and localization of deoxyribonuclease I in the rat ovary.","volume":"57","author":"Boone","year":"1997","journal-title":"Biol. Reprod"},{"key":"B9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-micro-092412-155620","article-title":"Wall teichoic acids of gram-positive bacteria.","volume":"67","author":"Brown","year":"2013","journal-title":"Annu. Rev. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197047","article-title":"A new era of antibiotics: the clinical potential of antimicrobial peptides.","volume":"21","author":"Browne","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00005-009-0057-2","article-title":"Cathelicidin LL-37: a multitask antimicrobial peptide.","volume":"58","author":"Bucki","year":"2010","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"B12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-0029-1214158","article-title":"Osteomyelitis of the long bones.","volume":"23","author":"Calhoun","year":"2009","journal-title":"Semin. Plast. Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1128\/AAC.01513-06","article-title":"Experimental phage therapy against Staphylococcus aureus in mice.","volume":"51","author":"Capparelli","year":"2007","journal-title":"Antimicrob. Agents Chemother"},{"key":"B14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy.","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.702484","article-title":"Impact of the host-microbiome on osteomyelitis pathogenesis.","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Mol. Biosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1159\/000366387","article-title":"Involvement of toll-like receptor 2 and pro-apoptotic signaling pathways in bone remodeling in osteomyelitis.","volume":"34","author":"Chen","year":"2014","journal-title":"Cell. Physiol. Biochem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.joms.2014.07.004","article-title":"Bisphosphonate uptake in areas of tooth extraction or periapical disease.","volume":"72","author":"Cheong","year":"2014","journal-title":"J. Oral Maxillofac. Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1099\/mic.0.063016-0","article-title":"Staphylococcus aureus protein A binding to osteoblast tumour necrosis factor receptor 1 results in activation of nuclear factor kappa B and release of interleukin-6 in bone infection.","volume":"159","author":"Claro","year":"2013","journal-title":"Microbiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.diagmicrobio.2013.04.025","article-title":"Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections.","volume":"76","author":"Claros","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111918","article-title":"Antimicrobial peptides in the battle against orthopedic implant-related infections: a review.","volume":"13","author":"Costa","year":"2021","journal-title":"Pharmaceutics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.actbio.2010.11.005","article-title":"Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces.","volume":"7","author":"Costa","year":"2011","journal-title":"Acta Biomater."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jfb12010008","article-title":"Poly(methyl methacrylate) bone cement composite can be refilled with antibiotics after implantation in femur or soft tissue.","volume":"12","author":"Cyphert","year":"2021","journal-title":"J. Funct. Biomater."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004152","article-title":"Broad-spectrum anti-biofilm peptide that targets a cellular stress response.","volume":"10","author":"de la Fuente-Nunez","year":"2014","journal-title":"PLoS Pathog."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/v9030050","article-title":"A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms.","volume":"9","author":"Doss","year":"2017","journal-title":"Viruses"},{"key":"B25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev-genet-112618-043641","article-title":"Mechanisms of DNA uptake by naturally competent bacteria.","volume":"53","author":"Dubnau","year":"2019","journal-title":"Annu. Rev. Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8070209","article-title":"Staphylococcus aureus toxins and diabetic foot ulcers: role in pathogenesis and interest in diagnosis.","volume":"8","author":"Dunyach-Remy","year":"2016","journal-title":"Toxins"},{"key":"B27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/infdis\/jir266","article-title":"The combination of a tumor necrosis factor inhibitor and antibiotic alleviates Staphylococcal arthritis and sepsis in mice.","volume":"204","author":"Fei","year":"2011","journal-title":"J. Infect. Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00198-010-1326-y","article-title":"Do RANKL inhibitors (Denosumab) affect inflammation and immunity?","volume":"22","author":"Ferrari-Lacraz","year":"2011","journal-title":"Osteoporos. Int"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.joen.2019.05.011","article-title":"Microbiological aspects of traumatic injuries.","volume":"45","author":"Fouad","year":"2019","journal-title":"J. Endod"},{"key":"B30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/bc050091v","article-title":"Preparation of LL-37-grafted titanium surfaces with bactericidal activity.","volume":"17","author":"Gabriel","year":"2006","journal-title":"Bioconjug. Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1590\/S1517-838220100004000025","article-title":"Microbiota associated with chronic osteomyelitis of the jaws.","volume":"41","author":"Gaetti-Jardim","year":"2010","journal-title":"Braz. J. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2666-5247(21)00127-0","article-title":"Clinical phage microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy.","volume":"2","author":"Gelman","year":"2021","journal-title":"Lancet Microbe"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1302\/2058-5241.6.210073","article-title":"A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety.","volume":"6","author":"Geneviere","year":"2021","journal-title":"Efort Open Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1302\/0301-620X.103B2.BJJ-2020-0452.R2","article-title":"Bacteriophage therapy for bone and joint infections.","author":"Gibb","year":"2021","journal-title":"Bone Joint J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ijos.2017.28","article-title":"Doxycycline induces bone repair and changes in Wnt signalling.","volume":"9","author":"Gomes","year":"2017","journal-title":"Int. J. Oral Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/1874285801004010008","article-title":"A comparison of bacterial composition in diabetic ulcers and contralateral intact skin.","volume":"4","author":"Gontcharova","year":"2010","journal-title":"Open Microbiol. J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.copbio.2020.10.002","article-title":"Unlocking the next generation of phage therapy: the key is in the receptors.","volume":"68","author":"Gordillo Altamirano","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.2147\/IJN.S268941","article-title":"Sesamol-loaded PLGA nanosuspension for accelerating wound healing in diabetic foot ulcer in rats.","volume":"15","author":"Gourishetti","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: from the natural environment to infectious diseases.","volume":"2","author":"Hall-Stoodley","year":"2004","journal-title":"Nat. Rev. Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9100635","article-title":"Progress overview of bacterial two-component regulatory systems as potential targets for antimicrobial chemotherapy.","volume":"9","author":"Hirakawa","year":"2020","journal-title":"Antibiotics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/phar.1135","article-title":"Local antimicrobial administration for prophylaxis of surgical site infections.","volume":"32","author":"Huiras","year":"2012","journal-title":"Pharmacotherapy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1902\/jop.2007.070073","article-title":"RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.","volume":"78","author":"Jin","year":"2007","journal-title":"J. Periodontol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10020158","article-title":"Bacteria and host interplay in Staphylococcus aureus septic arthritis and sepsis.","volume":"10","author":"Jin","year":"2021","journal-title":"Pathogens"},{"key":"B44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature07755","article-title":"A three-dimensional view of the molecular machinery of RNA interference.","volume":"457","author":"Jinek","year":"2009","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humic.2017.09.002","article-title":"The diabetic foot microbiota: a review.","author":"Jneid","year":"2017","journal-title":"Hum. Microbiome J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1016\/j.biomaterials.2005.01.001","article-title":"Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.","volume":"26","author":"Joosten","year":"2005","journal-title":"Biomaterials"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2015.00085","article-title":"Staphylococcus aureus vs. osteoblast: relationship and consequences in osteomyelitis.","volume":"5","author":"Josse","year":"2015","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/CMR.00069-15","article-title":"Clinical significance and pathogenesis of Staphylococcal small colony variants in persistent infections.","volume":"29","author":"Kahl","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.4049\/jimmunol.1601114","article-title":"Soluble RANKL cleaved from activated lymphocytes by TNF-alpha-converting enzyme contributes to osteoclastogenesis in periodontitis.","volume":"197","author":"Kanzaki","year":"2016","journal-title":"J. Immunol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00084-17","article-title":"Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions.","volume":"31","author":"Kavanagh","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jac\/dkt374","article-title":"Oral antibiotic treatment of staphylococcal bone and joint infections in adults.","volume":"69","author":"Kim","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0971-5916.178615","article-title":"Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model.","volume":"143","author":"Kishor","year":"2016","journal-title":"Indian J. Med. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL.","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1128\/IAI.01334-12","article-title":"Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway.","volume":"81","author":"Kwiecinski","year":"2013","journal-title":"Infect. Immun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0167-4781(99)00145-1","article-title":"Antisense properties of peptide nucleic acid.","volume":"1489","author":"Larsen","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.175","article-title":"Bone: finding that osteoclasts repel osteoblast activity through Sema4D reveals novel target for bone-boosting therapies.","volume":"7","author":"Leah","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1177\/0022034518781765","article-title":"Activity of Streptococcus mutans VicR is modulated by antisense RNA.","volume":"97","author":"Lei","year":"2018","journal-title":"J. Dent. Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/1758-2229.12907","article-title":"Quantitative acetylome analysis reveals involvement of glucosyltransferase acetylation in Streptococcus mutans biofilm formation.","volume":"13","author":"Lei","year":"2021","journal-title":"Environ. Microbiol. Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis.","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1021\/ja0584875","article-title":"Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.","volume":"128","author":"Li","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"B61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.3791","article-title":"Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.","volume":"21","author":"Liang","year":"2015","journal-title":"Nat. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2337\/db12-1325","article-title":"Diabetic foot ulcer microbiome: one small step for molecular microbiology \u2026 One giant leap for understanding diabetic foot ulcers?","volume":"62","author":"Lipsky","year":"2013","journal-title":"Diabetes"},{"key":"B63","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.biomaterials.2015.02.007","article-title":"A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts.","volume":"52","author":"Liu","year":"2015","journal-title":"Biomaterials"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06570-x","article-title":"Transformation of amorphous calcium phosphate to bone-like apatite.","volume":"9","author":"Lotsari","year":"2018","journal-title":"Nat. Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00051","article-title":"The factors affecting effectiveness of treatment in phages therapy.","volume":"5","author":"Ly-Chatain","year":"2014","journal-title":"Front. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5194\/jbji-7-23-2022","article-title":"Diagnosis of vertebral osteomyelitis.","volume":"7","author":"Maamari","year":"2022","journal-title":"J. Bone Jt. Infect"},{"key":"B67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ijbiomac.2018.12.240","article-title":"In vitro evaluation of sustained ciprofloxacin release from kappa-carrageenan-crosslinked chitosan\/hydroxyapatite hydrogel nanocomposites.","volume":"126","author":"Mahdavinia","year":"2019","journal-title":"Int. J. Biol. Macromol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.2147\/IDR.S257517","article-title":"Acute hematogenous osteomyelitis in children: clinical presentation and management.","volume":"13","author":"McNeil","year":"2020","journal-title":"Infect. Drug Resist"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4616","article-title":"Role of operative or interventional radiology-guided cultures for osteomyelitis.","volume":"137","author":"McNeil","year":"2016","journal-title":"Pediatrics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s10856-012-4711-6","article-title":"New antibacterial microporous CaP materials loaded with phages for prophylactic treatment in bone surgery.","volume":"23","author":"Meurice","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1128\/AAC.14.3.336","article-title":"Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.","volume":"14","author":"Miller","year":"1978","journal-title":"Antimicrob. Agents Chemother"},{"key":"B72","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/08927014.2017.1332186","article-title":"Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria.","volume":"33","author":"Mishra","year":"2017","journal-title":"Biofouling"},{"key":"B73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jcpt.12030","article-title":"The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults.","volume":"38","author":"Moenster","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01766-16","article-title":"Covalent immobilization of enoxacin onto titanium implant surfaces for inhibiting multiple bacterial species infection and in vivo methicillin-resistant Staphylococcus aureus infection prophylaxis.","volume":"61","author":"Nie","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev.med.56.062904.144915","article-title":"Aptamers: an emerging class of therapeutics.","volume":"56","author":"Nimjee","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1757-7861.2011.00146.x","article-title":"The effect of Staphylococcus aureus on apoptosis of cultured human osteoblasts.","volume":"3","author":"Ning","year":"2011","journal-title":"Orthop. Surg"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/cid\/ciz222","article-title":"Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination.","volume":"69","author":"Nir-Paz","year":"2019","journal-title":"Clin. Infect. Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/430161a","article-title":"The RNAi revolution.","volume":"430","author":"Novina","year":"2004","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/jb.117.1.215-221.1974","article-title":"Surface-bound nuclease of Staphylococcus aureus: localization of the enzyme.","volume":"117","author":"Okabayaski","year":"1974","journal-title":"J. Bacteriol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01736-21","article-title":"Bacteriophage therapy for the prevention and treatment of fracture-related infection caused by Staphylococcus aureus: a preclinical study.","volume":"9","author":"Onsea","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B81","doi-asserted-by":"publisher","first-page":"193","DOI":"10.22203\/eCM.v039a13","article-title":"Bacteriophage therapy as a treatment strategy for orthopaedic-device-related infections: where do we stand?","volume":"39","author":"Onsea","year":"2020","journal-title":"Eur. Cell Mater."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1517\/17425247.2015.1021679","article-title":"Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering.","volume":"12","author":"Ossipov","year":"2015","journal-title":"Expert Opin. Drug Deliv"},{"key":"B83","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1128\/IAI.00318-08","article-title":"Human host defense peptide LL-37 prevents bacterial biofilm formation.","volume":"76","author":"Overhage","year":"2008","journal-title":"Infect. Immun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/ma13143220","article-title":"A new insight into coating\u2019s formation mechanism between TiO2 and alendronate on titanium dental implant.","volume":"13","author":"Petrovic","year":"2020","journal-title":"Materials"},{"key":"B85","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection.","volume":"5","author":"Petrovic Fabijan","year":"2020","journal-title":"Nat. Microbiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1128\/JB.00017-16","article-title":"Antibiofilm peptides: potential as broad-spectrum agents.","volume":"198","author":"Pletzer","year":"2016","journal-title":"J. Bacteriol."},{"key":"B87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1128\/microbiolspec.GPP3-0069-2019","article-title":"Respiration and small colony variants of Staphylococcus aureus.","volume":"7","author":"Proctor","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrmicro1384","article-title":"Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections.","volume":"4","author":"Proctor","year":"2006","journal-title":"Nat. Rev. Microbiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27020536","article-title":"Small drugs, huge impact: the extraordinary impact of antisense oligonucleotides in research and drug development.","volume":"27","author":"Quemener","year":"2022","journal-title":"Molecules"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02866","article-title":"Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions.","volume":"10","author":"Raheem","year":"2019","journal-title":"Front. Microbiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/infdis\/jit005","article-title":"Quantitation and composition of cutaneous microbiota in diabetic and nondiabetic men.","volume":"207","author":"Redel","year":"2013","journal-title":"J. Infect. Dis"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/08927014.2013.823541","article-title":"Aggregatibacter actinomycetemcomitans biofilm killing by a targeted ciprofloxacin prodrug.","volume":"29","author":"Reeves","year":"2013","journal-title":"Biofouling"},{"key":"B93","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1128\/AAC.03163-14","article-title":"A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms.","volume":"58","author":"Reffuveille","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003720","article-title":"A tissue engineering solution for segmental defect regeneration in load-bearing long bones.","volume":"4","author":"Reichert","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/17453678909150107","article-title":"Antibiotic treatment insufficient for established septic arthritis. Staphylococcus aureus experiments in rabbits.","volume":"60","author":"Riegels-Nielsen","year":"1989","journal-title":"Acta Orthop. Scand."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.878965","article-title":"Bioinformatic analysis reveals hub immune-related genes of diabetic foot ulcers.","volume":"9","author":"Rong","year":"2022","journal-title":"Front. Surg"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102157","article-title":"Multitasking by the OC lineage during bone infection: bone resorption, immune modulation, and microbial niche.","volume":"9","author":"Roper","year":"2020","journal-title":"Cells"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122085","article-title":"The development of third-generation tetracycline antibiotics and new perspectives.","volume":"13","author":"Rusu","year":"2021","journal-title":"Pharmaceutics"},{"key":"B99","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jinf.2017.07.007","article-title":"Bone responses in health and infectious diseases: a focus on osteoblasts.","volume":"75","author":"Saint-Pastou Terrier","year":"2017","journal-title":"J. Infect."},{"key":"B100","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-4632.2004.02108.x","article-title":"Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity.","volume":"43","author":"Sanchez","year":"2004","journal-title":"Int. J. Dermatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-187","article-title":"Staphylococcus aureus biofilms decrease osteoblast viability, inhibits osteogenic differentiation, and increases bone resorption in vitro.","volume":"14","author":"Sanchez","year":"2013","journal-title":"BMC Musculoskelet. Disord"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.590","article-title":"Synergy as a rationale for phage therapy using phage cocktails.","volume":"2","author":"Schmerer","year":"2014","journal-title":"PeerJ"},{"key":"B103","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.idc.2017.01.010","article-title":"Osteomyelitis.","volume":"31","author":"Schmitt","year":"2017","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1021\/acs.jmedchem.6b01615","article-title":"Design, synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms.","volume":"60","author":"Sedghizadeh","year":"2017","journal-title":"J. Med. Chem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1128\/IAI.06276-11","article-title":"Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model.","volume":"80","author":"Settem","year":"2012","journal-title":"Infect. Immun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"21822","DOI":"10.1021\/am502591c","article-title":"Novel theranostic DNA nanoscaffolds for the simultaneous detection and killing of Escherichia coli and Staphylococcus aureus.","volume":"6","author":"Setyawati","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107473","article-title":"Recent advances in bone-targeted therapy.","volume":"207","author":"Shi","year":"2020","journal-title":"Pharmacol. Ther"},{"key":"B108","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/jac\/dkg443","article-title":"Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) from calcium phosphate bone substitutes.","volume":"52","author":"Stallmann","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B109","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s00223-015-9984-6","article-title":"The mineral-collagen interface in bone.","volume":"97","author":"Stock","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1111\/bph.15251","article-title":"Bisphosphonates for delivering drugs to bone.","volume":"178","author":"Sun","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1021\/acsnano.5b07828","article-title":"Osteoblast-targeting-peptide modified nanoparticle for siRNA\/microRNA delivery.","volume":"10","author":"Sun","year":"2016","journal-title":"ACS Nano"},{"key":"B112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/157016308783769405","article-title":"Targeted drug delivery to bone: pharmacokinetic and pharmacological properties of acidic oligopeptide-tagged drugs.","volume":"5","author":"Takahashi-Nishioka","year":"2008","journal-title":"Curr. Drug Discov. Technol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/annrheumdis-2018-214827","article-title":"Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.","volume":"78","author":"Takeuchi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cjtee.2020.05.009","article-title":"New perspectives on traumatic bone infections.","volume":"23","author":"Tang","year":"2020","journal-title":"Chin. J. Traumatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"17894","DOI":"10.1074\/jbc.M111.280511","article-title":"Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis.","volume":"287","author":"Toro","year":"2012","journal-title":"J. Biol. Chem"},{"key":"B116","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/infdis\/jiu386","article-title":"Dual impact of live Staphylococcus aureus on the osteoclast lineage, leading to increased bone resorption.","volume":"211","author":"Trouillet-Assant","year":"2015","journal-title":"J. Infect. Dis"},{"key":"B117","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1574-6968.2000.tb09096.x","article-title":"Intracellular Staphylococcus aureus induces apoptosis in mouse osteoblasts.","volume":"186","author":"Tucker","year":"2000","journal-title":"FEMS Microbiol. Lett"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00079","article-title":"Nanoscale drug delivery systems: from medicine to agriculture.","volume":"8","author":"Vega-Vasquez","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.bone.2009.10.028","article-title":"RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis.","volume":"46","author":"Verdrengh","year":"2010","journal-title":"Bone"},{"key":"B120","doi-asserted-by":"publisher","first-page":"31601","DOI":"10.1074\/jbc.M706078200","article-title":"Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways.","volume":"282","author":"Vitovski","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1086\/516962","article-title":"Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis.","volume":"25","author":"von Eiff","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.addr.2004.12.011","article-title":"Bone-targeting macromolecular therapeutics.","volume":"57","author":"Wang","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1021\/bc7002132","article-title":"Osteotropic Peptide that differentiates functional domains of the skeleton.","volume":"18","author":"Wang","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"B124","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.2147\/IJN.S88798","article-title":"Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.","volume":"10","author":"Wang","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"B125","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jcis.2010.04.081","article-title":"Studies on the sorption of tetracycline onto clays and marine sediment from seawater.","volume":"349","author":"Wang","year":"2010","journal-title":"J. Colloid Interface Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040586","article-title":"Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis.","volume":"7","author":"Widaa","year":"2012","journal-title":"PLoS One"},{"key":"B127","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijmm.2009.10.003","article-title":"Interaction of Staphylococci with bone.","volume":"300","author":"Wright","year":"2010","journal-title":"Int. J. Med. Microbiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jbm.a.36790","article-title":"Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo.","volume":"108","author":"Wroe","year":"2020","journal-title":"J. Biomed. Mater. Res. A"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111688","article-title":"An injectable and antibacterial calcium phosphate scaffold inhibiting Staphylococcus aureus and supporting stem cells for bone regeneration.","volume":"120","author":"Wu","year":"","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10121555","article-title":"The role of Staphylococcus aureus YycFG in gene regulation, biofilm organization and drug resistance.","volume":"10","author":"Wu","year":"","journal-title":"Antibiotics"},{"key":"B130","article-title":"An antisense yycF RNA modulates biofilm organization of methicillin-resistant Staphylococcus aureus and pathogenicity in a rat model of osteomyelitis.","volume":"10","author":"Wu","year":"","journal-title":"Antibiotics"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.749910","article-title":"A bone-targeting enoxacin delivery system to eradicate Staphylococcus aureus-related implantation infections and bone loss.","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Bioeng. Biotechnol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2106\/JBJS.K.01135","article-title":"Bacteriophage therapy in implant-related infections: an experimental study.","volume":"95","author":"Yilmaz","year":"2013","journal-title":"J. Bone Joint Surg. Am"},{"key":"B134","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy.","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med"},{"key":"B135","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1016\/j.cub.2015.11.017","article-title":"Antimicrobial peptides.","volume":"26","author":"Zhang","year":"2016","journal-title":"Curr. Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1021\/acs.nanolett.8b02166","article-title":"Inhibiting methicillin-resistant Staphylococcus aureus by tetrahedral DNA nanostructure-enabled antisense peptide nucleic acid delivery.","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett"},{"key":"B137","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/jbmr.2322","article-title":"Anabolic bone formation via a site-specific bone-targeting delivery system by interfering with semaphorin 4D expression.","volume":"30","author":"Zhang","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-020-0409-3","article-title":"Multi-targeted antisense oligonucleotide delivery by a framework nucleic acid for inhibiting biofilm formation and virulence.","volume":"12","author":"Zhang","year":"2020","journal-title":"Nanomicro Lett"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3892\/ijmm.2013.1346","article-title":"\u2019Staphylococcus aureus supernatant induces the release of mouse beta-defensin-14 from osteoblasts via the p38 MAPK and NF-kappaB pathways.","volume":"31","author":"Zhu","year":"2013","journal-title":"Int. J. Mol. Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/apm.12687","article-title":"Orthopaedic biofilm infections.","volume":"125","author":"Zimmerli","year":"2017","journal-title":"APMIS"},{"key":"B141","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jcb.1202","article-title":"Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism.","volume":"83","author":"Zou","year":"2001","journal-title":"J. Cell. Biochem"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.936285\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T10:15:30Z","timestamp":1655201730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.936285\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":141,"alternative-id":["10.3389\/fmicb.2022.936285"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.936285","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"article-number":"936285"}}